Approval · Notice of Compliance 24397 · 2020
ORILISSA: Notice of Compliance 24397
Issued October 8, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24397
- Date
- October 8, 2020
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision of drug product specification and addition of a new drug product impurites test method
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORILISSA | Not yet assigned | — |